Potential prognostic implications of myocardial thallium-201 and iodine-123-beta-methylpentadecanoic acid dual scintigraphy in patients with Anderson-Fabry disease.
201Tl/123I-BMIPP dual scintigraphy
Anderson–Fabry disease
Defect score
Prognosis
Journal
Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
16
08
2019
accepted:
26
09
2019
pubmed:
13
10
2019
medline:
9
4
2020
entrez:
13
10
2019
Statut:
ppublish
Résumé
Information on the relationship between myocardial damage assessed by myocardial scintigraphy and prognosis in patients with Anderson-Fabry disease (AFD) is lacking. We therefore aimed to investigate the prognostic impacts of myocardial thallium-201 ( Eighteen consecutive patients with AFD underwent resting myocardial Six major adverse cardiac events (MACEs) were recorded during a mean follow-up of 6.7 ± 4.2 years (three heart failure requiring hospitalization and three cardiac deaths). Left ventricular mass index, left atrial diameter, brain natriuretic peptide, TDS on TDS on
Identifiants
pubmed: 31605355
doi: 10.1007/s12149-019-01406-0
pii: 10.1007/s12149-019-01406-0
doi:
Substances chimiques
Fatty Acids
0
Iodobenzenes
0
Thallium Radioisotopes
0
iodofiltic acid
0J7USQ749M
Thallium-201
H91Z8HBK1B
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM